XML 16 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations - USD ($)
 12 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Operating Expenses:    
Research and development $ 4,083,303 $ 3,034,152
General and administration expenses 3,253,412 2,313,870
Total Operating Expenses 7,336,715 5,348,022
Loss From Operations (7,336,715) (5,348,022)
Other Income (Expenses):    
Interest income 130 28,749
Interest expense (39,791) 0
Loss Before Income Taxes (7,376,376) (5,319,273)
Provision for Income Taxes 1,600 1,600
Net Loss $ (7,377,976) $ (5,320,873)
Net Loss Per Share:    
Basic and Diluted $ (0.40) $ (0.3)
Weighted average number of shares used in computing basic and diluted net loss per share:    
Basic and Diluted 18,634,686 17,864,769